The Food and Drug Administration (FDA) approved the first generic versions of Vyvanse (lisdexamfetamine dimesylate) in August 2023 [1]. These generics are available in capsule and chewable tablet formulations [2].
What's the difference between brand-name Vyvanse and its generics?
Generic drugs are required to have the same active ingredient, dosage form, strength, route of administration, quality, performance characteristics, and intended use as their brand-name counterparts [3]. The primary difference for consumers is typically the cost, as generics are generally less expensive [3].
When did generic Vyvanse become available?
Generic lisdexamfetamine dimesylate became available in the United States following the FDA's approval in August 2023 [1].
Who manufactures generic Vyvanse?
Several companies have received FDA approval to market generic versions of Vyvanse. These include Teva Pharmaceuticals and Alora Pharmaceuticals, among others [1][4].
What are the benefits of generic Vyvanse?
The main benefit of generic Vyvanse is its lower cost compared to the brand-name medication [3]. This can improve access to treatment for individuals managing conditions like ADHD.
How does lisdexamfetamine dimesylate work?
Lisdexamfetamine dimesylate is a prodrug that is converted in the body to dextroamphetamine, which is a central nervous system stimulant. It works by affecting neurotransmitters in the brain, such as dopamine and norepinephrine, which play a role in attention and impulse control [5].